Zoetis Scientists Present Positive Efficacy Data for Investigational Triple Combination Parasiticide at American Heartworm Society Meeting
Zoetis Inc. Class A (ZTS)
Last zoetis inc. class a earnings: 2/13 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
investor.zoetis.com
Company Research
Source: Business Wire
Triple combination product contains sarolaner, moxidectin and pyrantel PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. today announced that its scientists presented positive efficacy data for the company’s investigational, triple combination parasiticide product at the 2019 Triennial meeting of the American Heartworm Society (AHS) in New Orleans, La. Zoetis is developing a triple combination product containing sarolaner, moxidectin and pyrantel that is administered orally once a month as a preventative for heartworm disease and to treat and control ticks, fleas, and intestinal nematodes in dogs.The results from effectiveness studies in dogs treated with the combination product demonstrated that no adult heartworms were recovered from animals in the laboratory studies and no positive test results for adult heartworms were obtained from dogs in the field study. The product was well-tolerated in all studies presented.In addition, data from a separate study, which tested the efficacy of
Show less
Read more
Impact Snapshot
Event Time:
ZTS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZTS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZTS alerts
High impacting Zoetis Inc. Class A news events
Weekly update
A roundup of the hottest topics
ZTS
News
- Vanguard Health Care Fund's Strategic Moves in Q3 2024: A Focus on Zoetis Inc [Yahoo! Finance]Yahoo! Finance
- Zoetis Appoints Jamie Brannan to Newly Created Chief Commercial Officer RoleBusiness Wire
- Cattle & Porcine/Swine Reproductive Diseases Market, 2024-2029 - Industry Revenues to Reach $975.8 Million by 2029 as Demand for Disease Management Intensifies [Yahoo! Finance]Yahoo! Finance
- Is Zoetis Inc. (ZTS) The Best Pet Stock To Invest In According To Analysts? [Yahoo! Finance]Yahoo! Finance
- Zoetis to Participate in Jefferies London Healthcare ConferenceBusiness Wire
ZTS
Earnings
- 11/4/24 - Beat
ZTS
Sec Filings
- 11/14/24 - Form 3
- 11/12/24 - Form 8-K
- 11/4/24 - Form 10-Q
- ZTS's page on the SEC website